Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

Nature Immunology

Volumn 9, Issue 8, 2008, Pages 873-879

  Haworth, Oliver ^a   Cernadas, Manuela ^a   Yang, Rong ^b   Serhan, Charles N ^b   Levy, Bruce D ^a,b  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 23; INTERLEUKIN 6; LIPOXIN A; OMEGA 3 FATTY ACID; RESOLVIN E1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-23; LIPOXINS; LUNG; MICE;

EID: 47849086917     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1627     Document Type: Article

References (51)

1. Holgate, S.T. The epidemic of allergy and asthma. Nature 402 B2-B4 (1999).
2. Martinez Molina, D. et al. Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature 448, 613-616 (2007).
3. Busse, W.W. & Lemanske, R.F., Jr. Asthma. N. Engl. J. Med. 344 350-362 (2001).
4. Schwartz, J. & Weiss, S.T. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur. Respir. J. 7, 1821-1824 (1994).
5. Serhan, C.N. et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatry drugs and transcellular processing, J. Exp. Med. 192, 1197-1204 (2000).
6. Serhan, C.N. et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037 (2002).
7. Gilroy, D.W., Lawrence, T., Perretti, M. & Rossi, A.G. Inflammatory resolution: New opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416 (2004).
8. Serhan, C.N. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137 (2007).
9. Campbell, E.L. et al. Resolvin E1 promotes mucosal surface clearance of neutrophils: A new paradigm for inflammatory resolution. FASEB J. 21, 3162-3170 (2007).
10. Schwab, J.M., Chiang, N., Arita, M. & Serhan, C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007).
11. H-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350 (2007).
12. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
13. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116 1310-1316 (2006).
14. Langowski, J.L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461-465 (2006).
15. Chan, J.R. et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
16. Molet, S. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430-438 (2001).
17. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
18. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
19. Chen, Y. et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278, 17036-17043 (2003).
20. Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715-2725 (2006).
21. Pichavant, M. et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 205, 385-393 (2008).
22. Cheung, P.F., Wong, C.K. & Lam, C.W. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: Implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180, 5625-5635 (2008).
23. Yang, X.O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (2008).
24. 4. Nat. Med. 8, 1018-1023 (2002).
25. Bannenberg, G.L. et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355 (2005).
26. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
27. Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 (2006).
28. Yoshimoto, T., Yoshimoto, T., Yasuda, K., Mizuguchi, J. & Nakanishi, K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells; a novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 179, 4415-4423 (2007).
29. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936 (2006).
30. H17 and regulatory T cells. Nature 441, 235-238 (2006).
31. Sheibanie, A.F., Tadmori, I., Jing, H., Vassiliou, E. & Ganea, D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18, 1318-1320 (2004).
32. -/- mice. J. Biol. Chem. 283, 14182-14189 (2008).
33. Bonnans, C. et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. Biomed. Pharmacother. 61, 261-267 (2007).
34. Yago, T. et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9, R96 (2007).
35. Jovanovic, D.V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160, 3513-3521 (1998).
36. Arita, M. et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad Sci. USA 102, 7671-7676 (2005).
37. Hudert, C.A. et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA 103, 11276-11281 (2006).
38. Ivanov, S. et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am. J. Respir. Cell Mol. Biol. 36, 442-451 (2007).
39. Barczyk, A., Pierzchala, W. & Sozanska, E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97, 726-733 (2003).
40. + Treg development and function during allergic airway inflammation invivo. J. Clin. Invest. 115, 313-325 (2005).
41. De Rose, V. et al. IFN-γ inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis. J. Leukoc. Biol. 76, 423-432 (2004).
42. Tong, J. et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J. Exp. Med. 203, 1173-1184 (2006).
43. Yoshida, M. et al. Effect of interferon-gamma on allergic airway responses in interferon-γ-deficient mice. Am. J. Respir. Crit. Care Med. 166, 451-456 (2002).
44. Arita, M. et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722 (2005).
45. Cash, J.L. et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775 (2008).
46. Serhan, C.N. et al. Resolution of inflammation: State of the art, definitions and terms. FASEB J. 2, 325-332 (2007).
47. Fukunaga, K., Kohli, P., Bormans, C., Fredenburgh, L.E. & Levy, B.D. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J. Immunol. 174, 5033-5039 (2005).
48. Levy, B.D. et al. Diminished lipoxin biosynthesis in severe asthma. Am. J. Respir. Crit. Care Med. 172, 824-830 (2005).
49. Levy, B.D. et al. Protectin D1 Is generated in asthma and dampens airway Inflammation and hyperresponsiveness. J. Immunol. 178 496-502 (2007).
50. 4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912-3917 (2007).
51. Levy, B.D. et al. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: A 'stop' signaling switch for aspirin-triggered lipoxin A4. FASEB J. 13, 903-911 (1999).